JPH0925228A - Seamless soft capsule - Google Patents
Seamless soft capsuleInfo
- Publication number
- JPH0925228A JPH0925228A JP17743495A JP17743495A JPH0925228A JP H0925228 A JPH0925228 A JP H0925228A JP 17743495 A JP17743495 A JP 17743495A JP 17743495 A JP17743495 A JP 17743495A JP H0925228 A JPH0925228 A JP H0925228A
- Authority
- JP
- Japan
- Prior art keywords
- agar
- soft capsule
- water
- seamless soft
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007901 soft capsule Substances 0.000 title claims abstract description 34
- 229920001817 Agar Polymers 0.000 claims abstract description 43
- 239000008272 agar Substances 0.000 claims abstract description 41
- 235000010443 alginic acid Nutrition 0.000 claims abstract description 16
- 239000000783 alginic acid Substances 0.000 claims abstract description 16
- 229920000615 alginic acid Polymers 0.000 claims abstract description 16
- 229960001126 alginic acid Drugs 0.000 claims abstract description 16
- 150000004781 alginic acids Chemical group 0.000 claims abstract description 16
- 235000010987 pectin Nutrition 0.000 claims abstract description 12
- 239000001814 pectin Substances 0.000 claims abstract description 12
- 229920001277 pectin Polymers 0.000 claims abstract description 12
- 239000003381 stabilizer Substances 0.000 claims abstract description 12
- 235000010418 carrageenan Nutrition 0.000 claims abstract description 11
- 239000000679 carrageenan Substances 0.000 claims abstract description 11
- 229920001525 carrageenan Polymers 0.000 claims abstract description 11
- 229940113118 carrageenan Drugs 0.000 claims abstract description 11
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims abstract description 11
- 239000004014 plasticizer Substances 0.000 claims abstract description 10
- 150000005846 sugar alcohols Chemical class 0.000 claims abstract description 10
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- 235000000346 sugar Nutrition 0.000 claims abstract description 6
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 5
- 239000005017 polysaccharide Substances 0.000 claims abstract description 5
- 150000004804 polysaccharides Chemical class 0.000 claims abstract description 5
- 229920003169 water-soluble polymer Polymers 0.000 claims description 14
- 239000000126 substance Substances 0.000 claims description 11
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 150000008163 sugars Chemical class 0.000 claims description 4
- 150000007522 mineralic acids Chemical class 0.000 claims description 3
- 150000007524 organic acids Chemical class 0.000 claims description 3
- 239000004094 surface-active agent Substances 0.000 claims description 3
- 235000005985 organic acids Nutrition 0.000 claims description 2
- 239000002775 capsule Substances 0.000 abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 14
- 239000000463 material Substances 0.000 abstract description 6
- 241001465754 Metazoa Species 0.000 abstract description 4
- 210000004051 gastric juice Anatomy 0.000 abstract description 4
- 229920000642 polymer Polymers 0.000 abstract description 4
- 238000004040 coloring Methods 0.000 abstract description 3
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 2
- 230000007815 allergy Effects 0.000 abstract description 2
- 230000006866 deterioration Effects 0.000 abstract description 2
- 208000026935 allergic disease Diseases 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- 108010010803 Gelatin Proteins 0.000 description 9
- 239000008273 gelatin Substances 0.000 description 9
- 229920000159 gelatin Polymers 0.000 description 9
- 235000019322 gelatine Nutrition 0.000 description 9
- 235000011852 gelatine desserts Nutrition 0.000 description 9
- 235000011187 glycerol Nutrition 0.000 description 9
- 238000000034 method Methods 0.000 description 7
- 229910021645 metal ion Inorganic materials 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- -1 pa index Chemical class 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical group OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229960000292 pectin Drugs 0.000 description 4
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 4
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000032050 esterification Effects 0.000 description 3
- 238000005886 esterification reaction Methods 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 235000010356 sorbitol Nutrition 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000002702 enteric coating Substances 0.000 description 2
- 238000009505 enteric coating Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- HWPKGOGLCKPRLZ-UHFFFAOYSA-M monosodium citrate Chemical compound [Na+].OC(=O)CC(O)(C([O-])=O)CC(O)=O HWPKGOGLCKPRLZ-UHFFFAOYSA-M 0.000 description 2
- 235000018342 monosodium citrate Nutrition 0.000 description 2
- 239000002524 monosodium citrate Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- HZLCGUXUOFWCCN-UHFFFAOYSA-N 2-hydroxynonadecane-1,2,3-tricarboxylic acid Chemical compound CCCCCCCCCCCCCCCCC(C(O)=O)C(O)(C(O)=O)CC(O)=O HZLCGUXUOFWCCN-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229940040563 agaric acid Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- WPUMTJGUQUYPIV-JIZZDEOASA-L disodium (S)-malate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](O)CC([O-])=O WPUMTJGUQUYPIV-JIZZDEOASA-L 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000011167 hydrochloric acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 235000019265 sodium DL-malate Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000001394 sodium malate Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、易崩壊性のゼラチンフ
リーのシームレスカプセル皮膜に関するものである。FIELD OF THE INVENTION The present invention relates to an easily disintegrating gelatin-free seamless capsule film.
【0002】[0002]
【従来の技術】一般に、軟カプセル剤の皮膜は牛、豚な
どの動物の骨や皮を材料とするゼラチンを基材とし、こ
れにグリセリン、ソルビトールなどを配合して製造され
ている。しかしながら、ゼラチンはソフトカプセルの製
造に優れた特性を有する反面、異種蛋白質としての抗原
性の可能性、ペプタイド構造に由来する他の薬物との反
応する可能性-例えばアミノカルボニル反応による着色-
や崩壊延長の原因となる不溶化、過乾燥による割れ、吸
湿による張り付き等の物理化学的変化、ゼラチンの特異
臭などの課題を抱えている。そのため、ゼラチンの精
製、ゼラチンと反応性のある物質の配合の回避、包装に
よる調湿などで対応を図っているのが現状である。さら
に、市場での天然指向の高まりとともに、ゼラチン以外
の非動物性のソフトカプセル素材の開発が強く要望され
ている。そこで、これまでにゼラチンフリーのソフトカ
プセルの製造について様々な方法が提案されている。2. Description of the Related Art Generally, a film of a soft capsule is produced by using gelatin, which is a material of bone or skin of animals such as cows and pigs, as a base material, and glycerin, sorbitol and the like are added thereto. However, while gelatin has excellent properties for the production of soft capsules, it has the potential of being an antigenicity as a heterologous protein and the possibility of reacting with other drugs derived from the peptide structure-for example, coloring by the aminocarbonyl reaction-
There are problems such as insolubilization that causes disintegration and extension, cracking due to overdrying, physicochemical changes such as sticking due to moisture absorption, and peculiar odor of gelatin. For this reason, the current situation is to purify gelatin, avoid blending substances that are reactive with gelatin, and adjust the humidity by packaging. Furthermore, with the increase of natural orientation in the market, there is a strong demand for development of non-animal soft capsule materials other than gelatin. Therefore, various methods have been proposed so far for producing gelatin-free soft capsules.
【0003】このうち比較的よく知られているものに、
アルギニン酸と多価金属イオン、アルギン酸とペクチ
ン、金属イオンの組み合わせによる軟カプセル化(特開
平03ー68508号、特開平03ー285654号、
特開昭61ー44810号、特開昭58ー210841
号)、カラギーナンと金属イオンによる方法(特開昭6
0ー12943号)、寒天ソフトカプセル(特開平01
ー193216号)、寒天と腸溶性剤皮、寒天とメタア
クリル酸の組み合わせ(特開平05ー32543号、特
開昭57ー32230号)などがある。これらのうち、
アルギン酸、カラギーナン及びペクチンと金属イオンと
の組み合わせでは、これら高分子物質とカルシウムイオ
ンとの反応による非常に強固なイオン結合を利用してカ
プセル化されるため、得られる皮膜は水不溶性である。
寒天及び寒天と他剤との組み合わせによるカプセル形成
も寒天の水への溶解度の低さを利用している。これらの
方法は、ゼラチンが抗原となる可能性及びアミノーカル
ボニル反応を回避できるものの、むしろ腸溶性皮膜とし
てのメリットが強調されている発明である。Of these, the ones that are relatively well known are:
Soft encapsulation by a combination of alginic acid and polyvalent metal ions, alginic acid and pectin, and metal ions (JP-A 03-68508, JP-A 03-285654,
JP-A-61-44810, JP-A-58-210841
No.), a method using carrageenan and a metal ion (Japanese Patent Laid-Open Publication No. Sho 6-66
No. 0-12943), agar soft capsule (Japanese Patent Laid-Open No. 01-123
No. 193216), an agar and an enteric coating, and a combination of agar and methacrylic acid (JP-A-05-32543 and JP-A-57-32230). Of these,
The combination of alginic acid, carrageenan and pectin with metal ions is encapsulated by utilizing a very strong ionic bond due to the reaction between these polymeric substances and calcium ions, so that the obtained film is water-insoluble.
Capsule formation by agar and a combination of agar and other agents also utilizes the low solubility of agar in water. These methods are inventions in which the possibility that gelatin serves as an antigen and the amino-carbonyl reaction can be avoided, but rather the merit as an enteric coating is emphasized.
【0004】[0004]
【発明が解決しようとする課題】したがって、これら技
術で製造されたソフトカプセルは水及び胃液では崩壊し
にくい。また、アルギン酸、カラギーナン、ペクチンな
どを用いた皮膜では、製造過程で濃厚な塩化カルシウム
溶液等の溶液中に浸せきされるために、金属イオン等が
ソフトカプセル剤皮中に結合して存在する量以外に、金
属イオン及び塩素イオン等の陰イオンとして多量吸着さ
れ、通常のカプセル成型過程では、洗浄などによっても
除去が困難である。これら陰イオンはカプセルに内包さ
れた薬物の安定性への悪影響を及ぼし、またカプセル保
存時に皮膜構造のレオロジカルな性質の経時変化を起こ
すことが懸念される。Therefore, the soft capsules produced by these techniques are unlikely to disintegrate in water and gastric juice. Also, in the case of a film using alginic acid, carrageenan, pectin, etc., since it is immersed in a solution such as a concentrated calcium chloride solution during the manufacturing process, in addition to the amount of metal ions etc. bound and present in the soft capsule skin, However, it is adsorbed in large amounts as anions such as metal ions and chloride ions, and is difficult to remove even by washing in the usual capsule molding process. These anions adversely affect the stability of the drug encapsulated in the capsule, and it is feared that the rheological properties of the film structure change with time during storage of the capsule.
【0005】さらに、このようなソフトカプセル剤皮
は、胃での崩壊性の良いカプセル剤皮とすることも重要
な課題である。このことからゼラチンの持つ問題を解決
し、水及び胃液で崩壊しやすく、安全で、安定な品質の
ゼラチンフリーのソフトカプセル皮膜とその製造法の開
発が強く要望されてきている。そこで本発明者らは、こ
れら高分子について詳細な検討を重ねた結果、以下に示
す手段により課題を解決できることを見出し本発明を完
成した。Further, it is also an important issue to make such a soft capsule skin as a capsule skin having good disintegration in the stomach. From this, there has been a strong demand to solve the problems of gelatin, to develop a gelatin-free soft capsule film of safe and stable quality, which is easy to disintegrate in water and gastric juice, and a manufacturing method thereof. Therefore, the present inventors have completed the present invention by discovering that the problems can be solved by the means shown below as a result of detailed studies on these polymers.
【0006】[0006]
【課題を解決するための手段】本発明は、寒天及び水溶
性高分子を必須成分とするシームレスソフトカプセル皮
膜である。本発明はまた、シームレスソフトカプセル剤
において、皮膜が寒天及び水溶性高分子を必須構成成分
とするシームレスソフトカプセル剤である。本発明にお
けるシームレスソフトカプセル皮膜には、さらに可塑
剤、安定化剤を加えることができる。The present invention is a seamless soft capsule film containing agar and a water-soluble polymer as essential components. The present invention is also a seamless soft capsule in which the film contains agar and a water-soluble polymer as essential constituents. A plasticizer and a stabilizer can be further added to the seamless soft capsule film of the present invention.
【0007】本発明における水溶性高分子物質とは、具
体的には例えばアルギン酸、その誘導体、ペクチン及び
カラギーナン等を意味し、これらの水溶性高分子物質を
1種若しくは2種以上組み合わせて使用してもよい。ア
ルギン酸は通常ナトリウム塩であるが、遊離体であるか
塩であるかには限定されず、また塩の種類にも限定され
ない。アルギン酸はいずれのM/G比及び重合度でもよ
く、皮膜の性状に合わせて選択される。また、アルギン
酸誘導体は、より具体的にはアルギン酸プロピレングリ
コールエステル等であり、エステル化度が10以上で、
いずれのM/G比、重合度を用いてもよい。ペクチンは種
々のタイプのものが入手可能であるが、高メトキシタイ
プ(エステル化度50%以上)又は低メトキシタイプ
(エステル化度25%〜45%)のいずれのエステル化
度のものを使用してもよい。カラギーナンは分子中に硫
酸基を有し、数種のタイプ(カッパ、イオタ、ラムダ)
が存在するが、本発明ではいずれのタイプでも利用でき
る。The water-soluble polymer substance in the present invention specifically means, for example, alginic acid, its derivative, pectin and carrageenan, and these water-soluble polymer substances are used alone or in combination of two or more kinds. May be. Alginic acid is usually a sodium salt, but is not limited to a free form or a salt, and is not limited to a kind of salt. Alginic acid may have any M / G ratio and polymerization degree, and is selected according to the properties of the film. Further, more specifically, the alginic acid derivative is propylene glycol alginate, etc., and has a degree of esterification of 10 or more,
Any M / G ratio and degree of polymerization may be used. Various types of pectin are available, but either high methoxy type (esterification degree of 50% or more) or low methoxy type (esterification degree of 25% to 45%) is used. May be. Carrageenan has a sulfate group in the molecule and is of several types (kappa, iota, lambda).
However, any type can be used in the present invention.
【0008】また、本発明における可塑剤とは、例えば
糖、糖アルコール、多糖類及び多価アルコールから選ば
れる物質を意味し、これらの物質を1種若しくは2種以
上組み合わせて用いてもよい。The plasticizer in the present invention means a substance selected from, for example, sugars, sugar alcohols, polysaccharides and polyhydric alcohols, and these substances may be used alone or in combination of two or more.
【0009】糖及び糖アルコールとしては、蔗糖、マル
トース、グルコース、ソルビトール、マルチトール、キ
シリトール、マンニトール、エリスリトール等を挙げる
ことができ、2種以上を用いてもよい。多価アルコール
としてはグリセリン、グリコール類としてポリエチレン
グリコール類(分子量400〜6000)等を挙げるこ
とができる。Examples of sugars and sugar alcohols include sucrose, maltose, glucose, sorbitol, maltitol, xylitol, mannitol, erythritol, and two or more kinds may be used. Examples of the polyhydric alcohol include glycerin, and examples of the glycols include polyethylene glycols (molecular weight 400 to 6000).
【0010】多糖類としてパインデックスなどのデキス
トリン類、部分アルファ化でんぷん(例えば商品名PCS
として旭化成株式会社より入手できる)が使用できる。As the polysaccharides, dextrins such as pa index, partially pregelatinized starch (eg, trade name PCS
(Available from Asahi Kasei Co., Ltd.) can be used.
【0011】本発明にはまた、安定化剤を使用すること
ができる。安定化剤とは、アミノ酸、界面活性剤、有機
酸若しくはそれらの塩類及び無機酸を意味する。アミノ
酸の具体的な例としては、アスパラギン酸、リジン、グ
リシン、セリン、アラニン、ヒスチジン、フェニルアラ
ニンなどを挙げることができる。また、界面活性剤は水
素添加硬化ヒマシ油ポリオキシエチレン誘導体、蔗糖脂
肪酸エステル類、ポリソルベートなどを挙げることがで
きる。 有機酸、無機酸は例えば、クエン酸、リンゴ
酸、フマル酸、酒石酸、乳酸、リン酸、塩酸等であり、
これらは塩であってもよい。Stabilizers can also be used in the present invention. The stabilizer means an amino acid, a surfactant, an organic acid or salts thereof, and an inorganic acid. Specific examples of amino acids include aspartic acid, lysine, glycine, serine, alanine, histidine, and phenylalanine. Examples of the surfactant include hydrogenated hydrogenated castor oil polyoxyethylene derivative, sucrose fatty acid ester, and polysorbate. Organic acids, inorganic acids are, for example, citric acid, malic acid, fumaric acid, tartaric acid, lactic acid, phosphoric acid, hydrochloric acid,
These may be salts.
【0012】本発明における水溶性高分子の寒天に対す
る比率は特に限定されないが、通常は寒天100重量部
に対して水溶性高分子1〜150重量部であり、好まし
くは10〜120重量部であり、より好ましくは15〜
100重量部である。また、可塑剤の寒天に対する比率
は特に限定されないが、通常は寒天100重量部に対し
て可塑剤が10〜450重量部であり、好ましくは20
〜300重量部、より好ましくは30〜230重量部で
ある。The ratio of the water-soluble polymer to the agar in the present invention is not particularly limited, but it is usually 1 to 150 parts by weight, preferably 10 to 120 parts by weight with respect to 100 parts by weight of the agar. , More preferably 15 to
100 parts by weight. The ratio of the plasticizer to the agar is not particularly limited, but is usually 10 to 450 parts by weight, preferably 20 parts by weight, relative to 100 parts by weight of the agar.
To 300 parts by weight, more preferably 30 to 230 parts by weight.
【0013】安定化剤の寒天に対する比率は、特に限定
されないが通常は寒天100重量に対して、安定化剤が
0.5〜30重量部であり、好ましくは1〜25重量部、
より好ましくは3〜20重量部である。本発明における
寒天は、市販のものをそのまま用いることができる。The ratio of the stabilizer to the agar is not particularly limited, but the stabilizer is usually added to 100 parts by weight of the agar.
0.5 to 30 parts by weight, preferably 1 to 25 parts by weight,
It is more preferably 3 to 20 parts by weight. As the agar in the present invention, commercially available agar can be used as it is.
【0014】本発明におけるソフトカプセルは次の方法
で製造することができる。寒天、水溶性高分子、糖ある
いはグリセリンを十分混和し、加温用ジャケット付タン
クなどで予め60〜70℃に加温した温水中に攪拌しな
がら、少量ずつ加え、均一に分散させる。さらに、80
〜98℃で攪拌下に加温し溶解させる。液の透明感、ダ
マの消失、溶状の均質性を確認後、穏やかに攪拌しなが
ら冷却する。液温が50〜70℃に達した時点で、安定
化剤を添加し、溶解させ皮膜液を得る。次いで通常の方
法で目的としたシームレスカプセルを製造する。カプセ
ル皮膜には必要により色素、保存剤などを添加すること
ができる。The soft capsule of the present invention can be manufactured by the following method. Agar, water-soluble polymer, sugar or glycerin are sufficiently mixed, and the mixture is added little by little while stirring in warm water previously heated to 60 to 70 ° C. in a tank with a heating jacket or the like, and uniformly dispersed. In addition, 80
Warm under stirring at ~ 98 ° C to dissolve. After confirming the transparency of the liquid, disappearance of lumps, and homogeneity of the liquid state, cool with gentle stirring. When the liquid temperature reaches 50 to 70 ° C., a stabilizer is added and dissolved to obtain a film liquid. Then, the intended seamless capsule is produced by a usual method. If necessary, a dye, a preservative and the like can be added to the capsule film.
【0015】本発明によるソフトカプセルは以下のよう
な点で優れた性質を有する。 1)易崩壊性で、水、胃液においても容易に溶解する。
2)吸湿性が少ない。軟化しずらい。カプセル同志のハ
リツキが起こりにくい。3)アミノカルボニル反応に起
因する皮膜の着色、劣化を起こしにくい。4)動物素材
に起因するアレルギーの可能性が回避される。The soft capsule according to the present invention has excellent properties in the following points. 1) It is easily disintegrating and dissolves easily in water and gastric juice.
2) Low hygroscopicity. Hard to soften. Hardness of capsule comrades is unlikely to occur. 3) Coloring and deterioration of the film due to the aminocarbonyl reaction are unlikely to occur. 4) The possibility of allergies due to animal material is avoided.
【0016】本発明によるカプセル皮膜の構成のメカニ
ズムは以下のように考えられる。寒天は加温溶存時、分
子がランダムコイル状態で存在する。温度の低下ととも
にダブルへリックス構造の三次元ネットワークを取り、
ゲルが形成される(ゾルーゲル転移30〜50℃)。こ
れは熱可塑性である(融点85〜93℃)。すなわち寒
天ゲルはその構成成分のひとつであるアガロペクチンの
酸性基を利用し強アルカリ性にするか、融点以上に加温
しない限り、水への溶解は難しい。本発明においては寒
天の強固なネットワーク構造がカプセル皮膜の骨格を形
成しているものと考えられる。一方、アルギン酸、ペク
チン、カラギーナンは、これら単独ではもろいゲルとな
り成型性に劣る。ゲル強度の強い寒天をベースとして比
較的強いネットワークを造り、そのネットワークの中へ
アルギン酸、ペクチン等の親水性物質を入り込ませるこ
とにより、ネットワーク内への水の導入経路が構築さ
れ、皮膜の崩壊性を高めることが可能となったと考えら
れる。ここで用いられる親水性物質は、前述の水溶性高
分子のアルギン酸ナトリウム、アルギン酸プロピレング
リコール、ペクチン、カラギーナンであり、さらに可塑
剤の糖、糖アルコール、多価アルコール、多糖類、安定
化剤のアミノ酸、有機酸塩、無機酸塩である。The mechanism of the constitution of the capsule coating according to the present invention is considered as follows. When agar is dissolved by heating, molecules exist in a random coil state. Taking a three-dimensional network of double helix structure as the temperature decreases,
A gel is formed (sol-gel transition 30-50 ° C). It is thermoplastic (melting point 85-93 ° C). That is, agar gel is difficult to dissolve in water unless it is made strongly alkaline by utilizing the acidic group of agaropectin, which is one of its constituents, or it is heated above its melting point. In the present invention, it is considered that the strong agar network structure forms the skeleton of the capsule film. On the other hand, alginic acid, pectin, and carrageenan are fragile gels when used alone, and are inferior in moldability. By creating a relatively strong network based on agar, which has a strong gel strength, and by allowing hydrophilic substances such as alginic acid and pectin to enter into the network, a pathway for introducing water into the network is constructed and the disintegration of the film It is thought that it has become possible to increase the The hydrophilic substances used here are the water-soluble polymers sodium alginate, propylene glycol alginate, pectin, and carrageenan, and further sugars as plasticizers, sugar alcohols, polyhydric alcohols, polysaccharides, amino acids as stabilizers. , Organic acid salts and inorganic acid salts.
【0017】[0017]
【実施例】以下に本発明を実施例を挙げて詳細に説明す
るが、本発明はこれらの実施例に限定されない。 実施例1 寒天28g、ソルビット15gを精製水2000mlに
分散させ、煮沸溶解する。寒天が完全に溶解した後、6
0〜70℃に冷却し、次いでアルギン酸プロピレングリ
コール6g、グリセリン20g、リンゴ酸ナトリウム1
gの混和物を加えて溶解し皮膜液とする。常法にしたが
って薬物を溶解した綿実油を内溶液とするシームレスソ
フトカプセルを得た。EXAMPLES The present invention is described in detail below with reference to examples, but the present invention is not limited to these examples. Example 1 28 g of agar and 15 g of sorbit are dispersed in 2000 ml of purified water and dissolved by boiling. 6 after the agar has completely dissolved
Cool to 0-70 ° C., then propylene glycol alginate 6 g, glycerin 20 g, sodium malate 1
g of the mixture is added and dissolved to form a film solution. According to a conventional method, seamless soft capsules containing cottonseed oil in which a drug was dissolved as an internal solution were obtained.
【0018】実施例2 寒天50g、ソルビット30gを精製水2000mlに
分散させ、煮沸溶解する。寒天が完全に溶解した後、約
60℃に冷却、保温し、次いでアルギン酸プロピレング
リコール18g、グリセリン34g、アスパラギン酸2
g、ソルビット5gおよびクエン酸二水素ナトリウム1.
5g のの混和物を均一に溶解し、皮膜液とし、実施例1
と同様にして、内溶液とするシームレスソフトカプセル
を得た。Example 2 50 g of agar and 30 g of sorbit are dispersed in 2000 ml of purified water and dissolved by boiling. After the agar was completely dissolved, it was cooled to about 60 ° C and kept warm, then 18 g of propylene glycol alginate, 34 g of glycerin, 2 parts of aspartic acid.
g, sorbitol 5 g and sodium dihydrogen citrate 1.
Example 1 was prepared by uniformly dissolving 5 g of the mixture to obtain a film solution.
In the same manner as described above, seamless soft capsules as an internal solution were obtained.
【0019】実施例3 寒天45gを精製水1500mlに分散させ、蒸発溶解
する。寒天が完全に溶解した後、50〜60℃に冷却、
保温し、ペクチン13g、グリセリン20g、アラニン
2.5gの混和物を溶解して皮膜液を製造し、実施例1と同
様にシームレスソフトカプセルを得た。Example 3 45 g of agar was dispersed in 1500 ml of purified water, and dissolved by evaporation. After the agar is completely dissolved, cool to 50-60 ° C,
Keep warm, pectin 13g, glycerin 20g, alanine
2.5 g of the mixture was dissolved to produce a film liquid, and seamless soft capsules were obtained in the same manner as in Example 1.
【0020】実施例4 寒天40gとグリセリン25gを混和後、精製水210
0mlに分散させ、煮沸溶解する。寒天が完全に溶解し
た後、60〜70℃に冷却、保温し、次いでカラギーナ
ン30g、ソルビット5g、グリシン4g、クエン酸二
水素ナトリウム1gの混和物を加えて溶解し皮膜液を得
た。実施例1と同様にしてシームレスソフトカプセルを
得た。Example 4 After mixing 40 g of agar and 25 g of glycerin, purified water 210 was added.
Disperse in 0 ml and dissolve by boiling. After the agar was completely dissolved, the mixture was cooled to 60 to 70 ° C. and kept warm, and then a mixture of 30 g of carrageenan, 5 g of sorbit, 4 g of glycine and 1 g of sodium dihydrogen citrate was added and dissolved to obtain a film solution. Seamless soft capsules were obtained in the same manner as in Example 1.
【0021】比較例1 寒天50g、グリセリン25gを精製水2000mlに
分散させ、煮沸溶解する。これを比較皮膜とし、実施例
1と同様にシームレスソフトカプセルを得た。 比較例2 ゼラチン20g、グリセリン6gを精製水1000ml
に分散させ、70〜80℃に加温、溶解する。これを比
較皮膜とし、実施例1と同様にシームレスソフトカプセ
ルを得た。実施例1〜4及び比較例1〜2について、製
造直後、冷凍庫(ー20℃)、45℃、40℃75%R
Hの各条件での1週間、1〜3ヶ月間保存後のカプセル
の諸物性を測定し表1〜4に示した。表5には、ゼラチ
ンカプセルと本発明による寒天系カプセルの特徴を要約
した。Comparative Example 1 50 g of agar and 25 g of glycerin are dispersed in 2000 ml of purified water and dissolved by boiling. Using this as a comparative film, seamless soft capsules were obtained in the same manner as in Example 1. Comparative Example 2 20 g of gelatin and 6 g of glycerin were added to 1000 ml of purified water.
Disperse in, and heat at 70-80 ° C. to dissolve. Using this as a comparative film, seamless soft capsules were obtained in the same manner as in Example 1. Regarding Examples 1 to 4 and Comparative Examples 1 and 2, immediately after production, a freezer (−20 ° C.), 45 ° C., 40 ° C. 75% R
Various physical properties of the capsules after storage for 1 week and 1 to 3 months under each condition of H were measured and shown in Tables 1 to 4. Table 5 summarizes the characteristics of the gelatin capsule and the agar-based capsule according to the present invention.
【表1】 [Table 1]
【表2】 [Table 2]
【表3】 [Table 3]
【表4】 [Table 4]
【表5】 [Table 5]
Claims (11)
ームレスソフトカプセル皮膜。1. A seamless soft capsule film containing agar and a water-soluble polymer as essential components.
ームレスソフトカプセル皮膜。2. A seamless soft capsule film comprising agar, a water-soluble polymer and a plasticizer.
からなるシームレスソフトカプセル皮膜。3. A seamless soft capsule film comprising agar, a water-soluble polymer, a plasticizer and a stabilizer.
塩、アルギン酸誘導体、カラギーナン及びペクチンから
選ばれる1以上の物質である請求項1ないし3いずれか
1項記載のシームレスソフトカプセル皮膜。4. The seamless soft capsule film according to claim 1, wherein the water-soluble polymer is one or more substances selected from alginic acid or a salt thereof, an alginic acid derivative, carrageenan and pectin.
価アルコールから選ばれる1以上の物質である請求項2
又は3記載のシームレスソフトカプセル皮膜。5. The plasticizer is one or more substances selected from sugars, sugar alcohols, polysaccharides and polyhydric alcohols.
Or the seamless soft capsule film described in 3.
若しくはその塩類及び無機酸から選ばれる1以上の物質
である請求項3記載のソフトカプセル皮膜。6. The soft capsule film according to claim 3, wherein the stabilizer is one or more substances selected from amino acids, surfactants, organic acids or salts thereof, and inorganic acids.
1〜150重量部である請求項1〜3いずれか1項記載
のシームレスソフトカプセル皮膜。7. The seamless soft capsule film according to claim 1, wherein the water-soluble polymer is 1 to 150 parts by weight with respect to 100 parts by weight of agar.
450重量部である請求項2又は3記載のシームレスソ
フトカプセル皮膜。8. A plasticizer of 10 parts by weight per 100 parts by weight of agar.
The seamless soft capsule film according to claim 2, which is 450 parts by weight.
5〜30重量部である請求項3記載のシームレスソフト
カプセル皮膜。9. Stabilizer is added to 100 parts by weight of agar in an amount of 0.
The seamless soft capsule film according to claim 3, which is 5 to 30 parts by weight.
皮膜が寒天及び水溶性高分子を必須構成成分とするシー
ムレスソフトカプセル剤。10. In a seamless soft capsule,
A seamless soft capsule whose film contains agar and water-soluble polymer as essential components.
酸誘導体、カラギーナン、ペクチンである請求項10記
載のシームレスソフトカプセル剤。11. The seamless soft capsule according to claim 10, wherein the water-soluble polymer is alginic acid, an alginic acid derivative, carrageenan, or pectin.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17743495A JP3879941B2 (en) | 1995-07-13 | 1995-07-13 | Seamless soft capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17743495A JP3879941B2 (en) | 1995-07-13 | 1995-07-13 | Seamless soft capsule |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0925228A true JPH0925228A (en) | 1997-01-28 |
| JP3879941B2 JP3879941B2 (en) | 2007-02-14 |
Family
ID=16030885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP17743495A Expired - Fee Related JP3879941B2 (en) | 1995-07-13 | 1995-07-13 | Seamless soft capsule |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3879941B2 (en) |
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2767070A1 (en) * | 1997-08-08 | 1999-02-12 | Laurence Paris | AQUEOUS VISCOUS COMPOSITION, LIMPID OR NOT, FOR THE MANUFACTURE OF SOFT CAPSULES AND HARD CAPSULES, AND METHOD FOR MANUFACTURING FILMS FOR SUCH CAPSULES |
| WO2000027367A1 (en) * | 1998-11-11 | 2000-05-18 | Bioprogress Technology International Incorporated | A capsule based drug delivery system |
| US6340473B1 (en) | 1999-07-07 | 2002-01-22 | R.P. Scherer Technologies, Inc. | Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same |
| WO2003084516A1 (en) * | 2002-04-04 | 2003-10-16 | Fmc Biopolymer As | Polysaccharide capsules and methods of preparation |
| KR100814034B1 (en) * | 2006-11-27 | 2008-03-14 | (주)아모레퍼시픽 | Cosmetic capsule composition and its manufacturing method |
| JP2008546400A (en) * | 2005-06-21 | 2008-12-25 | ヴェ. マヌ フィル | Smoking device incorporating a collapsible capsule, collapsible capsule, and method of manufacturing the capsule |
| US7766637B2 (en) | 2006-03-03 | 2010-08-03 | Fmc Corporation | Method and apparatus for the preparation of capsules |
| JP2013504574A (en) * | 2009-09-10 | 2013-02-07 | エフ エム シー コーポレーション | Seamless alginate capsules with high strength |
| JP2013139419A (en) * | 2011-12-30 | 2013-07-18 | Sansho Kaken Kk | Method for producing softgel type external preparation, softening liquid, and softgel type external preparation |
| WO2015115072A1 (en) | 2014-01-31 | 2015-08-06 | 富士カプセル株式会社 | Capsule formulation |
| WO2018225770A1 (en) * | 2017-06-09 | 2018-12-13 | 富士カプセル株式会社 | Seamless capsule coating composition and seamless capsule |
| JP2019112383A (en) * | 2017-12-26 | 2019-07-11 | 三生医薬株式会社 | Method of producing soft capsule |
| JP2021516257A (en) * | 2018-03-02 | 2021-07-01 | キャプテック ソフトジェル インターナショナル、インコーポレイテッド | Softgel composition and capsules made from it |
| JP7231796B1 (en) * | 2021-12-24 | 2023-03-01 | 株式会社カマタ | SEAMLESS CAPSULE AND METHOD FOR PRODUCING THE SAME |
| CN116725974A (en) * | 2023-07-03 | 2023-09-12 | 华侨大学 | Application of gel composition in preparation of medical compressed plant source soft capsules |
| EP4041022A4 (en) * | 2019-10-09 | 2023-11-01 | R.P. Scherer Technologies, LLC | NON-ANIMAL SOFT GEL CAPSULE FORMULATIONS, METHOD FOR THEIR PRODUCTION AND USE THEREOF |
| JPWO2025142831A1 (en) * | 2023-12-28 | 2025-07-03 |
-
1995
- 1995-07-13 JP JP17743495A patent/JP3879941B2/en not_active Expired - Fee Related
Cited By (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2767070A1 (en) * | 1997-08-08 | 1999-02-12 | Laurence Paris | AQUEOUS VISCOUS COMPOSITION, LIMPID OR NOT, FOR THE MANUFACTURE OF SOFT CAPSULES AND HARD CAPSULES, AND METHOD FOR MANUFACTURING FILMS FOR SUCH CAPSULES |
| WO1999007347A1 (en) * | 1997-08-08 | 1999-02-18 | Laurence Paris | Aqueous viscous compositions, whether clear or not, for making soft or hard capsules, and method for making films for such capsules |
| WO2000027367A1 (en) * | 1998-11-11 | 2000-05-18 | Bioprogress Technology International Incorporated | A capsule based drug delivery system |
| USRE39079E1 (en) * | 1999-07-07 | 2006-04-25 | R.P. Scherer Technologies, Inc. | Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same |
| US6582727B2 (en) | 1999-07-07 | 2003-06-24 | R. P. Scherer Technologies, Inc. | Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same |
| US6340473B1 (en) | 1999-07-07 | 2002-01-22 | R.P. Scherer Technologies, Inc. | Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same |
| WO2003084516A1 (en) * | 2002-04-04 | 2003-10-16 | Fmc Biopolymer As | Polysaccharide capsules and methods of preparation |
| US7972620B2 (en) | 2002-04-04 | 2011-07-05 | Fmc Biopolymer As | Polysaccharide capsules and methods of preparation |
| US9017720B2 (en) | 2002-04-04 | 2015-04-28 | FMC Bioploymer AS | Polysaccharide capsules and method of preparation |
| JP2014166188A (en) * | 2005-06-21 | 2014-09-11 | V Mane Fils | Smoking device incorporating breakable capsule, breakable capsule, and production method for capsule |
| US10278418B2 (en) | 2005-06-21 | 2019-05-07 | V. Mane Fils | Smoking device incorporating a breakable capsule, breakable capsule and process for manufacturing said capsule |
| JP2008546400A (en) * | 2005-06-21 | 2008-12-25 | ヴェ. マヌ フィル | Smoking device incorporating a collapsible capsule, collapsible capsule, and method of manufacturing the capsule |
| US9339060B2 (en) | 2005-06-21 | 2016-05-17 | V. Mane Fils | Smoking device incorporating a breakable capsule, breakable capsule and process for manufacturing said capsule |
| JP2015037425A (en) * | 2005-06-21 | 2015-02-26 | ヴェ. マヌ フィル | Smoking device incorporating breakable capsule, breakable capsule, and production method for capsule |
| US8820331B2 (en) | 2005-06-21 | 2014-09-02 | V. Mane Fils | Smoking device incorporating a breakable capsule, breakable capsule and process for manufacturing said capsule |
| US8916192B2 (en) | 2006-03-03 | 2014-12-23 | Fmc Corporation | Method and apparatus for the preparation of capsules |
| US8153037B2 (en) | 2006-03-03 | 2012-04-10 | Fmc Corporation | Method and apparatus for the preparation of capsules |
| US7766637B2 (en) | 2006-03-03 | 2010-08-03 | Fmc Corporation | Method and apparatus for the preparation of capsules |
| KR100814034B1 (en) * | 2006-11-27 | 2008-03-14 | (주)아모레퍼시픽 | Cosmetic capsule composition and its manufacturing method |
| JP2013504574A (en) * | 2009-09-10 | 2013-02-07 | エフ エム シー コーポレーション | Seamless alginate capsules with high strength |
| US9895672B2 (en) | 2009-09-10 | 2018-02-20 | DuPont Nutrition USA, Inc. | High strength seamless alginate capsules |
| JP2013139419A (en) * | 2011-12-30 | 2013-07-18 | Sansho Kaken Kk | Method for producing softgel type external preparation, softening liquid, and softgel type external preparation |
| WO2015115072A1 (en) | 2014-01-31 | 2015-08-06 | 富士カプセル株式会社 | Capsule formulation |
| US11364206B2 (en) | 2017-06-09 | 2022-06-21 | Fuji Capsule Co., Ltd. | Seamless capsule shell composition and seamless capsule |
| WO2018225770A1 (en) * | 2017-06-09 | 2018-12-13 | 富士カプセル株式会社 | Seamless capsule coating composition and seamless capsule |
| JPWO2018225770A1 (en) * | 2017-06-09 | 2020-04-09 | 富士カプセル株式会社 | Composition for seamless capsule film and seamless capsule |
| JP2019112383A (en) * | 2017-12-26 | 2019-07-11 | 三生医薬株式会社 | Method of producing soft capsule |
| JP2021516257A (en) * | 2018-03-02 | 2021-07-01 | キャプテック ソフトジェル インターナショナル、インコーポレイテッド | Softgel composition and capsules made from it |
| EP4041022A4 (en) * | 2019-10-09 | 2023-11-01 | R.P. Scherer Technologies, LLC | NON-ANIMAL SOFT GEL CAPSULE FORMULATIONS, METHOD FOR THEIR PRODUCTION AND USE THEREOF |
| AU2020363824B2 (en) * | 2019-10-09 | 2026-01-08 | R.P. Scherer Technologies, Llc | Non-animal softgel capsule formulations, methods of preparation, and methods of use thereof |
| JP7231796B1 (en) * | 2021-12-24 | 2023-03-01 | 株式会社カマタ | SEAMLESS CAPSULE AND METHOD FOR PRODUCING THE SAME |
| WO2023119624A1 (en) * | 2021-12-24 | 2023-06-29 | 株式会社カマタ | Seamless capsule |
| CN116725974A (en) * | 2023-07-03 | 2023-09-12 | 华侨大学 | Application of gel composition in preparation of medical compressed plant source soft capsules |
| CN116725974B (en) * | 2023-07-03 | 2025-12-30 | 华侨大学 | Application of gel composition in the preparation of medical compressed plant-derived soft capsules |
| JPWO2025142831A1 (en) * | 2023-12-28 | 2025-07-03 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3879941B2 (en) | 2007-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3879941B2 (en) | Seamless soft capsule | |
| US20250099376A1 (en) | Pharmaceutical composition comprising ghb gastro-retentive raft forming systems having trigger pulse drug release | |
| ES2603225T3 (en) | Soft capsule system without gelatin | |
| TWI472323B (en) | Aqueous composition for enteric hard capsule, method of preparing enteric hard capsule,and enteric hard capsule prepared using the method | |
| JP3455962B2 (en) | Cellulose capsule using mixed solution of pectin and glycerin and method for producing the same | |
| CA2360647C (en) | Fast dispersing dosage forms free of gelatin | |
| JP4184278B2 (en) | Non-gelatin capsule coating composition and capsule using the same | |
| JP4294862B2 (en) | Gelatin composition | |
| US6509040B1 (en) | Fast dispersing dosage forms essentially free of mammalian gelatin | |
| US5874106A (en) | Filled gelatin capsules | |
| CN103087208B (en) | By the carrageenin of ion exchange method modification | |
| JP3672008B2 (en) | Hard capsule and method for producing the same | |
| KR102785453B1 (en) | Gel mass composition for enteric soft capsule | |
| JP5107584B2 (en) | Functional jelly composition and method for producing the same | |
| JP2001008634A (en) | Soluble polymerized gelatin, its production and method for adjusting its solubility | |
| WO2002064120A1 (en) | Gel preparations for internal use | |
| JPH0620534B2 (en) | Water-soluble soft capsule | |
| KR100886542B1 (en) | Solubilization composition of sibutramine and preparation method thereof | |
| KR101591713B1 (en) | Process for preparing transparent soft capsule for acidic drug with flat form system which dissolves hydoxide ion species | |
| KR102013296B1 (en) | Aqueous composition for hard capsule, method of preparing the aqueous composition and hard capsule prepared thereof | |
| JP2004250369A (en) | Coating film composition for soft capsule | |
| Bhowmik et al. | Properties of Polymers Enabling In Situ Gel Formation | |
| HK1037536B (en) | Fast dispersing dosage forms free of gelatin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20050408 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050603 |
|
| A911 | Transfer of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20050610 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20060705 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20061102 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20061102 |
|
| R150 | Certificate of patent (=grant) or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091117 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101117 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111117 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111117 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121117 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131117 Year of fee payment: 7 |
|
| LAPS | Cancellation because of no payment of annual fees |